✦ LIBER ✦

The importance of clinical trials in unraveling the mysteries of multiple sclerosis

✍ Scribed by Henry McFarland

Book ID: 113730821
Publisher: Elsevier Science
Year: 2011
Tongue: English
Weight: 445 KB
Volume: 231
Category: Article
ISSN: 0165-5728
DOI: 10.1016/j.jneuroim.2010.12.010

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Methodology of clinical trials in multip

Methodology of clinical trials in multiple sclerosis

✍ D. D. Mitsikostas 📂 Article 📅 2006 🏛 Springer Milan 🌐 English ⚖ 37 KB

Unravelling the mystery of the TACT tria

Unravelling the mystery of the TACT trial

✍ Miguel Martin 📂 Article 📅 2009 🏛 The Lancet 🌐 English ⚖ 75 KB

Clinical Trials of Copolymer I in Multip

Clinical Trials of Copolymer I in Multiple Sclerosis

✍ M. B. BORNSTEIN; A. I. MILLER; S. SLAGLE; R. ARNON; M. SELA; D. TEITELBAUM 📂 Article 📅 1984 🏛 John Wiley and Sons 🌐 English ⚖ 413 KB

[Handbook of Clinical Neurology] Multipl

[Handbook of Clinical Neurology] Multiple Sclerosis and Related Disorders Volume 122 || Clinical trials in multiple sclerosis

✍ Cutter, Gary 📂 Article 📅 2014 🏛 Elsevier 🌐 English ⚖ 112 KB

Multiple Sclerosis (MS) is generally understood to be an inflammatory autoimmune disease of the central nervous system. While we still are not certain of the root cause of MS, research results suggest that unknown environmental factors and the presence of specific genes seem the most probable targe

Clinical trials of immunosuppression and

Clinical trials of immunosuppression and immunomodulation in multiple sclerosis

✍ Ludwig Kappos 📂 Article 📅 1988 🏛 Elsevier Science 🌐 English ⚖ 660 KB

Lessons from clinical trials of alemtuzu

Lessons from clinical trials of alemtuzumab in multiple sclerosis

✍ Chaudhuri, Abhijit; Behan, Peter O. 📂 Article 📅 2013 🏛 Elsevier 🌐 English ⚖ 301 KB